http://www.w3.org/ns/prov#value | - icular hypertrophy ???First report of an event, in some cases the patient died subsequently to the event reported ??Death due to heart failure, non-coronary vascular disease, pulmonary embolism, or a cardiovascular cause other than stroke or coronary heart disease Although the LIFE study favored losartan potassium over atenolol with respect to the primary endpoint (p=0.021), this result is from a
|